Altered dynamic insulin pulsatile, altered insulin clearance, hyperglucagonemia, and hepatic glucagon resistance are parts of NAFLD pathogenesis in type 1 DM. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.